जेफिरनेट लोगो

न्यूरोपेस नीधम 23वें वार्षिक हेल्थकेयर सम्मेलन में प्रस्तुति देगा | बायोस्पेस

दिनांक:

MOUNTAIN VIEW, Calif., March 27, 2024 (GLOBE NEWSWIRE) — न्यूरोपेस, इंक। (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will present at the Needham 23rd Annual Healthcare Conference, taking place virtually from April 8-11.

Joel Becker, NeuroPace’s Chief Executive Officer, will provide a corporate presentation on Monday, April 8 at 3:45pm ET, and management will participate in one-on-one meetings with investors during the conference.

The presentation will be accessible via a live webcast यहाँ उत्पन्न करें. A webcast replay of the presentation will be available on the Events section of NeuroPace’s Investor website at https://investors.neuropace.com/news-and-events/events.

न्यूरोपेस, इंक. के बारे में
Based in Mountain View, Calif., NeuroPace is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders.

निवेशक संपर्क:
जेरेमी फेफ़र
प्रबंध निदेशक
LifeSci सलाहकार
jfeffer@lifesciadvisors.com


प्राथमिक लोगो

स्पॉट_आईएमजी

नवीनतम खुफिया

स्पॉट_आईएमजी